Stevens D L
Veterans Affairs Medical Center, Infectious Diseases Section, Boise, ID 83702, USA.
Int J Med Microbiol. 2000 Oct;290(4-5):497-502. doi: 10.1016/S1438-4221(00)80074-0.
These pieces of evidence can be assimilated into a molecular and cellular model of pathogenesis which is initiated by direct toxin effects upon venous capillary endothelial cell function, leading to expression of pro-inflammatory mediators and adhesion molecules, and initiation of platelet aggregation. Toxin-induced hyperadhesion of leukocytes (see above section) with enhanced respiratory burst activity (due to toxins directly or to toxin-induced IL-8 or PAF synthesis by host cells) and toxin-induced chemotaxis deficits could result in neutrophil-mediated vascular injury. Direct toxin-induced cytopathic effects on EC may also contribute to vascular abnormalities associated with gas gangrene. Over prolonged incubation periods, PLC at sublytic concentrations causes EC to undergo profound shape changes similar to those described following prolonged TNF or interferon gamma exposure. In vivo, conversion of EC to this fibroblastoid morphology could contribute to the localized vascular leakage and massive swelling observed clinically with this infection. Similarly, the direct cytotoxicity of PFO could disrupt endothelial integrity and contribute to progressive edema both locally and systemically. Thus, via the mechanisms outlined above, both PLC and PFO may cause local, regional and systemic vascular dysfunction. For instance, local absorption of exotoxins within the capillary beds could affect the physiological function of the endothelium lining the postcapillary venules, resulting in impairment of phagocyte delivery at the site of infection. Toxin-induced endothelial dysfunction and microvascular injury could also cause loss of albumin, electrolytes, and water into the interstitial space resulting in marked localized edema. These events, combined with intravascular platelet aggregation and leukostasis, would increase venous pressures and favor further loss of fluid and protein in the distal capillary bed. Ultimately, a reduced arteriolar flow would impair oxygen delivery thereby attenuating phagocyte oxidative killing and facilitating anaerobic glycolysis of muscle tissue. The resultant drop in tissue pH, together with reduced oxygen tension, might further decrease the redox potential of viable tissues to a point suitable for growth of this anaerobic bacillus. As infection progresses and additional toxin is absorbed, larger venous channels would become affected, causing regional vascular compromise, increased compartment pressures and rapid anoxic necrosis of large muscle groups. When toxins reach arterial circulation, systemic shock and multiorgan failure rapidly ensue, and death is common.
这些证据可被整合到一个发病机制的分子和细胞模型中,该模型由毒素对静脉毛细血管内皮细胞功能的直接作用引发,导致促炎介质和黏附分子的表达,并引发血小板聚集。毒素诱导的白细胞超黏附(见上文部分)以及增强的呼吸爆发活性(由于毒素直接作用或宿主细胞毒素诱导的IL-8或PAF合成)和毒素诱导的趋化性缺陷可能导致中性粒细胞介导的血管损伤。毒素对内皮细胞的直接细胞病变效应也可能导致与气性坏疽相关的血管异常。在延长的孵育期内,亚裂解浓度的磷脂酶C会使内皮细胞发生深刻的形态变化,类似于长时间暴露于肿瘤坏死因子或干扰素γ后所描述的变化。在体内,内皮细胞转化为这种成纤维细胞样形态可能导致临床上观察到的局部血管渗漏和大量肿胀。同样,穿孔素的直接细胞毒性可能破坏内皮完整性,并导致局部和全身的进行性水肿。因此,通过上述机制,磷脂酶C和穿孔素都可能导致局部、区域和全身血管功能障碍。例如,毛细血管床中外毒素的局部吸收可能影响毛细血管后微静脉内皮的生理功能,导致感染部位吞噬细胞输送受损。毒素诱导的内皮功能障碍和微血管损伤也可能导致白蛋白、电解质和水进入间质空间,导致明显的局部水肿。这些事件,加上血管内血小板聚集和白细胞淤滞,会增加静脉压力,并有利于远端毛细血管床进一步流失液体和蛋白质。最终,小动脉血流减少会损害氧气输送,从而减弱吞噬细胞的氧化杀伤作用,并促进肌肉组织的无氧糖酵解。由此导致的组织pH值下降,加上氧张力降低,可能会进一步降低存活组织的氧化还原电位,达到适合这种厌氧杆菌生长的程度。随着感染进展和更多毒素被吸收,更大的静脉通道会受到影响,导致区域血管受损、腔室压力增加以及大肌肉群迅速缺氧坏死。当毒素进入动脉循环时,会迅速引发全身休克和多器官衰竭,死亡很常见。